TGFB1 and neoplasm: As shown in Fig. 8, SBE treatment significantly down-regulated Th17 and Treg related cytokine, IL-17 (Fig. 8c), TGF-β (Fig. 8a), IL-10 (Fig. 8b) in the serum of tumor bearing mice (P < 0.01).